WallStreetZenWallStreetZen

NASDAQ: BCYC
Bicycle Therapeutics PLC Stock Ownership - Who owns Bicycle Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bicycle Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael SkynnerCHIEF TECHNOLOGY OFFICER2026-01-053,266$6.46
$21.10kSell
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2026-01-052,367$6.45
$15.27kSell
Alethia YoungChief Financial Officer2026-01-052,456$6.45
$15.84kSell
Alethia YoungChief Financial Officer2026-01-051,878$6.54
$12.28kSell
Kevin LeeCHIEF EXECUTIVE OFFICER2026-01-0510,989$6.46
$70.99kSell
Alistair MilnesCHIEF OPERATING OFFICER2026-01-053,416$6.46
$22.07kSell
Travis Alvin ThompsonCHIEF ACCOUNTING OFFICER2026-01-051,115$6.45
$7.19kSell
Travis Alvin ThompsonCHIEF ACCOUNTING OFFICER2026-01-021,317$6.80
$8.96kSell
Alethia YoungChief Financial Officer2026-01-023,289$6.80
$22.37kSell
Kevin LeeCHIEF EXECUTIVE OFFICER2026-01-0210,325$6.80
$70.21kSell

1 of 5

BCYC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCYC insiders and whales buy or sell their stock.

BCYC Shareholders

What type of owners hold Bicycle Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP14.44%10,018,674$52.50MInsider
Westfield Capital Management Co LP4.35%3,016,026$15.80MInstitution
Siren LLC2.90%2,012,752$10.55MInstitution
Carolyn Ng2.88%1,998,580$10.47MInsider
Tybourne Capital Management Hk Ltd2.82%1,957,961$10.26MInsider
Deborah Harland2.76%1,915,275$10.04MInsider
Svlsf V LLC2.76%1,915,274$10.04MInsider
Glaxosmithkline PLC2.75%1,910,531$10.01MInsider
Kate Bingham2.75%1,910,016$10.01MInsider
Novartis Bioventures Ltd2.55%1,769,641$9.27MInsider

1 of 3

BCYC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCYC22.53%43.81%Net SellingNet Selling
MNPR6.99%93.01%Net SellingNet Selling
IVVD33.29%39.46%Net SellingNet Buying
AVIR44.35%28.60%Net BuyingNet Buying
VNDA44.56%55.44%Net Selling
View Top Biotech Stocks

Bicycle Therapeutics Stock Ownership FAQ

Who owns Bicycle Therapeutics?

Bicycle Therapeutics (NASDAQ: BCYC) is owned by 22.53% institutional shareholders, 43.81% Bicycle Therapeutics insiders, and 33.66% retail investors. Baker Bros Advisors LP is the largest individual Bicycle Therapeutics shareholder, owning 10.02M shares representing 14.44% of the company. Baker Bros Advisors LP's Bicycle Therapeutics shares are currently valued at $52.40M.

If you're new to stock investing, here's how to buy Bicycle Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.